contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


zealand-pharma-conference-call-on-february-20-at-2pm-cet-8am-et-to-present-full-year-2024-financial-results

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.

Zealand Pharma

Press Release – No. 3 / 2025 Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results Copenhagen, Denmark, February 13, 2025 – Zealand Pharma...

Press Release – No. 3 / 2025 Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results Copenhagen, Denmark,&nbsp;February 13, 2025&nbsp;–&nbsp;Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces that it will host a conference call on February 20, 2025, at 2:00 pm CET (8:00 am ET) following the announcement of financial results for the full year of 2024. Participating in the call will be President and Chief Executive Officer, Adam Steensberg; Chief Financial Officer, Henriette Wennicke; Chief Medical Officer, David Kendall; and Chief Commercial Officer, Eric Cox. There will be a presentation followed by a Q&amp;A session. The live listen-only audio webcast of the call and accompanying slide presentation will be accessible at <a href="https://www.globenewswire.com/Tracker?data=GKN2pYSwsLAexlU2Nm82NisgO4uuRTjihrWS996lTs0hnktTXWIFeFpuokS-MP54Dyq1v6U_pNFN8DGA5hNXoQy3iwouVytNfh10pUmZqBzLGikbdtQPmJPxg3nbgs650giaH59T5eYvdOrLmIuJV7A8okQJRSBtCrZ1RDrTfWE=">https://edge.media-server.com/mmc/p/96nk8pep</a>. To receive telephone dial-in information and a unique personal access PIN, please register at <a href="https://www.globenewswire.com/Tracker?data=GKN2pYSwsLAexlU2Nm82NqwsxoH4G1Pl3lUq7CQMN9Hh_XHM7_R6MYT-iLQP9kOO7cstx698lNtZvVx0AjH2e-TsQA96obsYGOZGsVR2jHawLgyeq0hq-WRIpjG0hI47BbAg_IbxTzH-U-rfs3lGHdxOYQfFCeyuakqmxl0cM78zuAHRaPXDc09lNebdqvj4mlqD62LNoCQW0leU0aIVXwmWB834o69QqcMn_UJGQBA=">https://register.vevent.com/register/BI735075144114493ead489441f1d0740f</a>. Participants are advised to register for the call or webcast approximately 10 minutes before the start. A recording of the event will be available following the call on the Investors section of Zealand Pharma’s website at <a href="https://www.globenewswire.com/Tracker?data=GKN2pYSwsLAexlU2Nm82Nh_vg2qh2N6oVbz_ZHObHlNR8VzMSLTrPR82s1LUyb5B4cwbTUNcGY7TquqBORqIDxRHAmXp7AbTRPjOe11Wv-bjYdVfu9AQpzMsP-txP9oOwjv4SrW5jQ5EWhMiY4hCVoNKD9L4puBuFeWvrbdKE0JXKcqCbMwkU-fEUqR7zBla8BjrvlK-lS3RcjCXS9t9fw==">https://www.zealandpharma.com/investors/events-presentations/</a>. About Zealand Pharma A/S Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma’s business and activities, please visit <a href="https://www.globenewswire.com/Tracker?data=BsdQVwhjhvh36KfHyVBoPgSenUAaa937qfA-_0gmREyoH-CC3QpuZnKBrcQ0lo1tqi0BS1ZF1Wc54p1EcsyxaFYy6e_6zViGu3aSxqzAFS4=">www.zealandpharma.com</a>. Contacts: Adam Lange (Investors) Investor Relations Officer Email: alange@zealandpharma.com Neshat Ahmadi (Investors) Investor Relations Manager Email: neahmadi@zealandpharma.com Anna Krassowska, PhD (Media and Investors) Vice President, Investor Relations &amp; Corporate Communications Email: akrassowska@zealandpharma.com <img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTA0ODMwOCM0MDIwNjAwMzEjMjAwMTcwMQ==" alt=""> <img src="https://ml-eu.globenewswire.com/media/YzFmNjIzMzAtOTIxNC00NWZiLWE5NjYtNThkZTRiZmY5OGRmLTEwMTMyNzQ=/tiny/Zealand-Pharma.png" alt="">

Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results